Jeffery Kutok

Chief Scientific Officer at Epizyme

Prior to joining Infinity in 2010, Dr. Kutok was an associate professor of pathology at Harvard Medical School and Brigham and Women’s Hospital, where his laboratory conducted preclinical and translational medicine research and biomarker identification in oncology. Dr. Kutok has published over 200 journal articles, reviews and book chapters, focused on hematologic malignancies and solid tumors. He received his B.S. in biology and his M.D., Ph.D. in medicine and molecular pathology from the State University of New York at Stony Brook. For his post-doctoral training, Dr. Kutok completed a residency in anatomic pathology and hematopathology at Brigham and Women’s Hospital and a research fellowship at Harvard University in the laboratory of Gary Gilliland, M.D., Ph.D., where he studied an epigenetic mechanism of leukemia pathogenesis.

Timeline

  • Chief Scientific Officer

    Current role

View in org chart